1. Home
  2. DLO vs LIVN Comparison

DLO vs LIVN Comparison

Compare DLO & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DLO

DLocal Limited

HOLD

Current Price

$13.60

Market Cap

4.5B

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$76.24

Market Cap

4.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLO
LIVN
Founded
2013
1987
Country
Uruguay
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.3B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
DLO
LIVN
Price
$13.60
$76.24
Analyst Decision
Strong Buy
Buy
Analyst Count
8
7
Target Price
$17.25
★ $72.43
AVG Volume (30 Days)
★ 1.4M
546.5K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
★ 1.45%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.33
Revenue
N/A
N/A
Revenue This Year
$41.00
$9.79
Revenue Next Year
$26.98
$6.63
P/E Ratio
★ $22.27
$33.14
Revenue Growth
N/A
N/A
52 Week Low
$10.64
$48.82
52 Week High
$16.78
$85.76

Technical Indicators

Market Signals
Indicator
DLO
LIVN
Relative Strength Index (RSI) 35.70 41.33
Support Level $13.14 $74.99
Resistance Level $15.55 $82.39
Average True Range (ATR) 0.37 2.04
MACD -0.11 -0.26
Stochastic Oscillator 0.00 31.98

Price Performance

Historical Comparison
DLO
LIVN

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company operates in a single operating segment, which is payment processing. The company's geographical segments include Latin America and Non-Latin America, with a majority of its revenue being generated from Brazil in the Latin America region.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: